480 related articles for article (PubMed ID: 21483675)
1. Chronic intranasal treatment with an anti-Aβ(30-42) scFv antibody ameliorates amyloid pathology in a transgenic mouse model of Alzheimer's disease.
Cattepoel S; Hanenberg M; Kulic L; Nitsch RM
PLoS One; 2011 Apr; 6(4):e18296. PubMed ID: 21483675
[TBL] [Abstract][Full Text] [Related]
2. Central amyloid-β-specific single chain variable fragment ameliorates Aβ aggregation and neurotoxicity.
Nisbet RM; Nigro J; Breheney K; Caine J; Hattarki MK; Nuttall SD
Protein Eng Des Sel; 2013 Oct; 26(10):571-80. PubMed ID: 23766374
[TBL] [Abstract][Full Text] [Related]
3. Improved Brain Expression of Anti-Amyloid β scFv by Complexation of mRNA Including a Secretion Sequence with PEG-based Block Catiomer.
Perche F; Uchida S; Akiba H; Lin CY; Ikegami M; Dirisala A; Nakashima T; Itaka K; Tsumoto K; Kataoka K
Curr Alzheimer Res; 2017; 14(3):295-302. PubMed ID: 27829339
[TBL] [Abstract][Full Text] [Related]
4. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
[TBL] [Abstract][Full Text] [Related]
5. Amelioration of amyloid load by anti-Abeta single-chain antibody in Alzheimer mouse model.
Fukuchi K; Accavitti-Loper MA; Kim HD; Tahara K; Cao Y; Lewis TL; Caughey RC; Kim H; Lalonde R
Biochem Biophys Res Commun; 2006 May; 344(1):79-86. PubMed ID: 16630540
[TBL] [Abstract][Full Text] [Related]
6. Intramuscular delivery of a single chain antibody gene prevents brain Aβ deposition and cognitive impairment in a mouse model of Alzheimer's disease.
Wang YJ; Gao CY; Yang M; Liu XH; Sun Y; Pollard A; Dong XY; Wu XB; Zhong JH; Zhou HD; Zhou XF
Brain Behav Immun; 2010 Nov; 24(8):1281-93. PubMed ID: 20595065
[TBL] [Abstract][Full Text] [Related]
7. Maysin and Its Flavonoid Derivative from Centipedegrass Attenuates Amyloid Plaques by Inducting Humoral Immune Response with Th2 Skewed Cytokine Response in the Tg (APPswe, PS1dE9) Alzheimer's Mouse Model.
Song Y; Kim HD; Lee MK; Hong IH; Won CK; Bai HW; Lee SS; Lee S; Chung BY; Cho JH
PLoS One; 2017; 12(1):e0169509. PubMed ID: 28072821
[TBL] [Abstract][Full Text] [Related]
8. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
9. SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer's disease.
Brunner D; Flunkert S; Neddens J; Duller S; Scopes DIC; Treherne JM; Hutter-Paier B
Neurosci Lett; 2017 Nov; 660():96-102. PubMed ID: 28917978
[TBL] [Abstract][Full Text] [Related]
10. Intracranial adeno-associated virus-mediated delivery of anti-pan amyloid beta, amyloid beta40, and amyloid beta42 single-chain variable fragments attenuates plaque pathology in amyloid precursor protein mice.
Levites Y; Jansen K; Smithson LA; Dakin R; Holloway VM; Das P; Golde TE
J Neurosci; 2006 Nov; 26(46):11923-8. PubMed ID: 17108166
[TBL] [Abstract][Full Text] [Related]
11. Pan-amyloid oligomer specific scFv antibody attenuates memory deficits and brain amyloid burden in mice with Alzheimer's disease.
Zhao M; Wang SW; Wang YJ; Zhang R; Li YN; Su YJ; Zhou WW; Yu XL; Liu RT
Curr Alzheimer Res; 2014 Jan; 11(1):69-78. PubMed ID: 24156260
[TBL] [Abstract][Full Text] [Related]
12. Receptor-mediated abeta amyloid antibody targeting to Alzheimer's disease mouse brain.
Zhou QH; Fu A; Boado RJ; Hui EK; Lu JZ; Pardridge WM
Mol Pharm; 2011 Feb; 8(1):280-5. PubMed ID: 21141969
[TBL] [Abstract][Full Text] [Related]
13. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice.
Zhang W; Zhang W; Li Z; Hao J; Zhang Z; Liu L; Mao N; Miao J; Zhang L
Pharmacol Biochem Behav; 2012 Jan; 100(3):361-9. PubMed ID: 21993310
[TBL] [Abstract][Full Text] [Related]
14. Effects of an Aβ-antibody fragment on Aβ aggregation and astrocytic uptake are modulated by apolipoprotein E and J mimetic peptides.
Montoliu-Gaya L; Mulder SD; Veerhuis R; Villegas S
PLoS One; 2017; 12(11):e0188191. PubMed ID: 29155887
[TBL] [Abstract][Full Text] [Related]
15. Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice.
Sigurdsson EM; Scholtzova H; Mehta PD; Frangione B; Wisniewski T
Am J Pathol; 2001 Aug; 159(2):439-47. PubMed ID: 11485902
[TBL] [Abstract][Full Text] [Related]
16. Disaggregation of amyloid plaque in brain of Alzheimer's disease transgenic mice with daily subcutaneous administration of a tetravalent bispecific antibody that targets the transferrin receptor and the Abeta amyloid peptide.
Sumbria RK; Hui EK; Lu JZ; Boado RJ; Pardridge WM
Mol Pharm; 2013 Sep; 10(9):3507-13. PubMed ID: 23924247
[TBL] [Abstract][Full Text] [Related]
17. A novel monoclonal antibody against the N-terminus of Aβ1-42 reduces plaques and improves cognition in a mouse model of Alzheimer's disease.
Xing HY; Li B; Peng D; Wang CY; Wang GY; Li P; Le YY; Wang JM; Ye G; Chen JH
PLoS One; 2017; 12(6):e0180076. PubMed ID: 28662102
[TBL] [Abstract][Full Text] [Related]
18. A Novel scFv Anti-Aβ Antibody Reduces Pathological Impairments in APP/PS1 Transgenic Mice via Modulation of Inflammatory Cytokines and Aβ-related Enzymes.
Hu M; Zhang J; Yang J; Cao Y; Qi J
J Mol Neurosci; 2018 Sep; 66(1):1-9. PubMed ID: 30062438
[TBL] [Abstract][Full Text] [Related]
19. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
[TBL] [Abstract][Full Text] [Related]
20. Naturally occurring autoantibodies against Aβ oligomers exhibited more beneficial effects in the treatment of mouse model of Alzheimer's disease than intravenous immunoglobulin.
Wang T; Xie XX; Ji M; Wang SW; Zha J; Zhou WW; Yu XL; Wei C; Ma S; Xi ZY; Pang GL; Liu RT
Neuropharmacology; 2016 Jun; 105():561-576. PubMed ID: 26907803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
